Zydus Lifesciences has announced a restructuring of its subsidiary, Zydus Foundation (ZF). As of November 19, 2025, ZF is no longer a wholly-owned subsidiary, following the allotment of 4,50,000 equity shares to Ramanbhai Foundation, a public charitable trust. Zydus Lifesciences continues to hold 50,000 equity shares in ZF post-allotment. This restructuring aims to further the philanthropic endeavors of both Foundations.
Zydus Foundation’s Share Restructuring
Zydus Lifesciences announced that Zydus Foundation (ZF) has ceased to be its wholly-owned subsidiary effective November 19, 2025. This follows the preferential issue and allotment of shares to Ramanbhai Foundation, a public charitable trust.
Details of Share Allotment
According to the announcement, 4,50,000 equity shares of ₹10 each were allotted to Ramanbhai Foundation on November 19, 2025. Post-allotment, Zydus Lifesciences continues to hold 50,000 equity shares in ZF.
Impact of the Transaction
The equity shares of ZF are subscribed by Ramanbhai Foundation, a public charitable trust at the fair value determined by the SEBI registered valuer. The equity issuance by ZF to the Ramanbhai Foundation has been carried out on an arm’s length basis.
Financial Contribution of Zydus Foundation
For the financial year ended March 31, 2025, Zydus Foundation’s contribution to the consolidated financial statements of the company was as follows:
- Income: Zero
- Net Worth: Zero
Source: BSE